Midmichigan Medical Center-gratiot | |
300 E Warwick Dr, Alma, Michigan 48801 | |
(989) 463-1101 | |
Name | Midmichigan Medical Center-gratiot |
---|---|
Type | Acute Care Hospital |
Location | 300 E Warwick Dr, Alma, Michigan |
Ownership | Voluntary non-profit - Private |
Emergency Services | Yes |
Medicare ID (CCN) | 230030 |
NPI Number | 1023097771 |
Organization Name | MYMICHIGAN MEDICAL CENTER ALMA |
Address | 300 E Warwick Dr, Alma, MI 48801 |
Hospital Type | General Acute Care Hospital |
Phone Number | 989-463-1101 |
News Archive
Cipher Pharmaceuticals Inc. today announced that Purdue Pharma Products L.P. and Napp Pharmaceutical Group Ltd. have filed a complaint against Cipher in the United States District Court for the Eastern District of Virginia, for alleged infringement of two U.S. patents. The action relates to Cipher's New Drug Application ("NDA") filed with the U.S. Food and Drug Administration ("FDA") for CIP TRAMADOL ER, the Company's extended-release tramadol product.
Optimer Pharmaceuticals, Inc. today announced positive top-line results from the second of two pivotal Phase 3 trials evaluating the safety and efficacy of fidaxomicin (OPT-80) in patients with Clostridium difficile Infection (CDI). This study was conducted in approximately 100 clinical sites throughout North America and Europe. The Company plans to use data from this study to support submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in the second half of 2010.
Tissue allocation is a growing issue of concern for many researchers due, in part, to expanding research interests in precision medicine. The increased demand by pharmaceutical and biotech companies for patient tissue specimens collected for clinical care and trials presents clinical, ethical, and legal issues.
Today's adolescents have been characterized as the most materialistic generation in history: a brand-oriented and consumer-involved group who derive self-worth from owning luxury handbags and the latest technology devices.
› Verified 6 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Cipher Pharmaceuticals Inc. today announced that Purdue Pharma Products L.P. and Napp Pharmaceutical Group Ltd. have filed a complaint against Cipher in the United States District Court for the Eastern District of Virginia, for alleged infringement of two U.S. patents. The action relates to Cipher's New Drug Application ("NDA") filed with the U.S. Food and Drug Administration ("FDA") for CIP TRAMADOL ER, the Company's extended-release tramadol product.
Optimer Pharmaceuticals, Inc. today announced positive top-line results from the second of two pivotal Phase 3 trials evaluating the safety and efficacy of fidaxomicin (OPT-80) in patients with Clostridium difficile Infection (CDI). This study was conducted in approximately 100 clinical sites throughout North America and Europe. The Company plans to use data from this study to support submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in the second half of 2010.
Tissue allocation is a growing issue of concern for many researchers due, in part, to expanding research interests in precision medicine. The increased demand by pharmaceutical and biotech companies for patient tissue specimens collected for clinical care and trials presents clinical, ethical, and legal issues.
Today's adolescents have been characterized as the most materialistic generation in history: a brand-oriented and consumer-involved group who derive self-worth from owning luxury handbags and the latest technology devices.
› Verified 6 days ago
Midmichigan Medical Center-gratiot Acute Care Hospital Location: 300 E Warwick Dr, Alma, Michigan 48801 Phone: (989) 463-1101 |